Liver Diseases Center
INSTITUTE
University Hospitals Digestive Health Institute
MEDICAL DIRECTOR
Pierre M. Gholam, MD | Pierre.Gholam@UHhospitals.org
KEY CONTACTS
Stanley Cohen, MD | Hepatology, Gastroenterology
Resham Ramkissoon, MD | Hepatology
Naemat Sandhu, MD | Gastroenterology, Hepatology
Seth Sclair, MD | Hepatology
Ashley Hepner, MD | Hepatology
Transplant | UH Transplant Institute
David Axelrod, MD | Transplant Surgery
Jody Jones, PhD | Psychology
Brianna Ruch, MD | Transplant Surgery
Zoe Stewart Lewis, MD | Transplant Surgery
Kai Zhao, MD | Transplant Surgery
Hepatocellular Carcinoma & Biliary Tract Cancers
Amit Mahipal, MD | Hematology and Oncology
APPOINTMENT LINE
For hospital transfers, please call 216-844-1111.
Coordinators and Contact Information
• For transplant referrals and intake, please call Pamela Diamond at 440-623-7049.
• For medical referrals to the Liver Diseases Center, please call Rhonda Wynn at 440-860-6370.
• For referrals for surgical treatment at the Liver Diseases Center, please call Linda Little at 440-870-9528, option 2.
• For hospital transfers, please call 216-844-1111.
Conditions Treated
- Chronic hepatitis C infection
- Non-alcoholic steatohepatitis (NASH)
- Fatty liver disease
- End-stage liver disease requiring liver transplantation
- Cirrhosis of the liver
- Hepatocellular carcinoma (primary liver cancer)
- Cholangiocarcinoma (bile duct cancer)
- Benign liver tumors (hemangioma, adenoma, FNH)
Therapies
- Liver transplantation
- Antiviral therapy for HCV infection
- Surgical resection of malignant and benign liver tumors
- Radiofrequency ablation for hepatocellular carcinoma
- Transarterial chemoembolization (TACE) for hepatocellular carcinoma
- Transarterial radioembolization (TARE/Y90) for hepatocellular carcinoma
- Systemic chemotherapy for hepatocellular carcinoma
Liver Diseases Center
- Chronic hepatitis B infection
- Alcoholic liver disease
- Primary biliary cholangitis
- Primary sclerosing cholangitis
- Hereditary hemochromatosis
- Vascular liver disease (portal vein thrombosis, Budd-Chiari syndrome)
- Alpha one antitrypsin deficiency
- Wilson disease
- Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma
- Antiviral therapy for hepatitis B
- Clinical trials for reversal of liver fibrosis/cirrhosis, fatty liver disease, hepatitis C and liver cancer
- Treatment of cholestatic liver disease
- Genetic testing and counseling for inherited disorders of the liver
- Phlebotomy and follow-up of hereditary hemochromatosis
Distinguishing Features
- Expedited evaluation of candidacy for liver transplantation for the patients who are most ill
- Multidisciplinary hepatobiliary tumor board, with broad participation from expert surgeons, hepatologists, medical oncologists, interventional radiologists, pathologists, radiation oncologists and palliative care specialists
- Nationally and internationally published quality and outcomes data
- Access to state-of-the-art treatment, including early-phase clinical trials for patients with liver cancer
- One of the largest hepatitis C treatment clinics in the U.S., with more than 1,000 patients treated and cured in the last two years
- Access to state-of-the-art clinical trials for all the latest investigational treatments for fatty liver disease
- Access to first-ever clinical trials for reversal of cirrhosis and liver fibrosis
- NIH-funded clinical and research program in alcoholic liver disease